4//SEC Filing
Gruis Kirsten L 4
Accession 0001235802-22-000013
CIK 0001401040other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:57 PM ET
Size
6.1 KB
Accession
0001235802-22-000013
Insider Transaction Report
Form 4
Gruis Kirsten L
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2022-01-03+160,000→ 160,000 totalExercise: $3.88Exp: 2032-01-02→ Common Shares (160,000 underlying)
Holdings
- 0
Voting Common Shares, no par value per share
Footnotes (1)
- [F1]This option vests with respect to 40,000 common shares on January 3, 2023 and with respect to the remaining 75% of the common shares in 36 nearly equal monthly installments commencing one month after the one-year anniversary of the grant date.
Documents
Issuer
DiaMedica Therapeutics Inc.
CIK 0001401040
Entity typeother
Related Parties
1- filerCIK 0001902629
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:57 PM ET
- Size
- 6.1 KB